| Literature DB >> 29774583 |
E Forbat1, F R Ali2, F Al-Niaimi2.
Abstract
Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents, which is used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In this article, we review the biological mechanisms of IVIg in dermatological disorders and the practicalities of its use, including its mechanism of action, dosing, availability, costs and adverse effects.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29774583 DOI: 10.1111/ced.13553
Source DB: PubMed Journal: Clin Exp Dermatol ISSN: 0307-6938 Impact factor: 3.470